Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Clinical trial NCT00092534 · COMPLETED

Trial details

NCT number: NCT00092534
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Genital Warts

Start date: 2002-06-14
Primary completion: 2007-07-31
Enrollment: 12167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.